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a  b  s  t  r  a  c  t
Current  biopharmaceutical  production  heavily  relies  on  chromatography  for protein  puriﬁcation.
Recently,  research  has intensiﬁed  towards  ﬁnding  suitable  solutions  to  monitoring  the  chromatographic
steps  by  multivariate  spectroscopic  sensors.  Here,  hard-constraint  multivariate  curve  resolution  (MCR)
was investigated  as a calibration-free  method  for factorizing  bilinear  preparative  protein  chromatograms
into  concentrations  and  spectra.  Protein  elutions  were  assumed  to follow  exponentially  modiﬁed  Gaus-
sian (EMG)  curves.  In three  case  studies,  MCR  was applied  to  chromatograms  of  second-derivative
ultraviolet  and  visible  (UV–vis)  spectra.  The  three  case  studies  consisted  of the  separation  of  a ternary  mix-
ture  (ribonuclease  A,  cytochrome  c, and lysozyme),  multiple  binary  chromatography  runs of cytochrome  c
and lysozyme,  and  the  separation  of  an  antibody–drug  conjugate  (ADC)  from  unconjugated  immunoglob-
2V–vis spectroscopy
hemometrics
iopharmaceuticals
ultivariate curve resolution
ulin  G (IgG).  In all case  studies,  good  estimates  of the elution  curves  were  obtained.  R values  compared
to  off-line  analytics  exceeded  0.90.  The  estimated  spectra  allowed  for protein  identiﬁcation  based  on  a
protein  spectral  library.  In summary,  MCR  was  shown  to  be  well  able  to  factorize  protein  chromatograms
without  prior  calibration.  The  method  may  thus  substantially  simplify  analysis  of  multivariate  protein
chromatograms  with  multiple  co-eluting  species.  It may  be especially  useful  in  process  development.
© 2018  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
In modern biopharmaceutical protein puriﬁcation, prepara-
ive chromatography is the method of choice for capturing and
olishing steps [1]. Chromatography is popular because it can
imultaneously deliver high purity and high yield. To achieve the
ecessary performance, chromatographic steps need to be well-
esigned. Already slight process changes can inﬂuence the quality
roﬁle of the product [2]. The situation is further complicated due to
he necessity of complex off-line analytical methods for assessing
he quality of biopharmaceuticals. As a means to improve pro-
ess monitoring, control and understanding in development and
roduction, process analytical technology (PAT) has raised a lot
f interest [3–7]. The goal of PAT is to develop and implement
ensors which allow for (near) real-time monitoring of quality
ttributes. Most frequently, on-line and at-line high performance
iquid chromatography (HPLC) has been used for different appli-
∗ Corresponding author.
E-mail address: juergen.hubbuch@kit.edu (J. Hubbuch).
ttps://doi.org/10.1016/j.chroma.2018.11.065
021-9673/© 2018 The Authors. Published by Elsevier B.V. This is an open access article 
/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
cations including the monitoring of capture and polishing steps
[8–13].
Recently, spectroscopic approaches in combination with multi-
variate data analysis (MVDA) for the retrieval of overlapping peaks
have become more popular [7]. Spectroscopic methods are often
non-invasive, fast, and robust [3]. They have been used for the selec-
tive in-situ quantiﬁcation of proteins in multi-well plates [14,15]
and selective in-line quantiﬁcation in preparative chromatogra-
phy [7,16–19]. These applications have in common that they use
spectroscopic data and partial-least squares (PLS) modeling for
selective protein quantiﬁcation. As PLS regression generates correl-
ative models, a calibration has to be performed prior to application.
Furthermore, the model may  be susceptible to degeneration and
needs to be tested regularly.
As an alternative method for evaluating spectra, MCR  has been
widely discussed [20–22]. MCR  maximizes the explained variance
of factors while physically or chemically meaningful constraints
are imposed on the behavior of the pure components. Predomi-
nantly employed in analytical chemistry, the evolution of MCR is
still ongoing, regarding both theory and application [21]. Neverthe-
less, it has already been used for the resolution of complex chemical
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ixtures since the 1980s [23,24]. Since then, different algorithms
ave been developed for various applications [21]. Regarding the
pplication of MCR  for the resolution of protein chromatograms,
iterature is scarce. Compared to small molecules, different pro-
ein spectra exhibit a lower degree of variability [15], which makes
esolution more challenging. Additionally, observed ‘pure’ pro-
ein spectra are often combinations of multiple heterogeneities.
uring a chromatographic elution, these heterogeneities may  be
eparated resulting in a variation of the spectra even for ‘pure’
omponents. Vandeginste et al. published a method for three-
omponent curve resolution of proteins in 1985 [25]. More recently,
 hybrid-MCR algorithm was shown to be able to determine accu-
ate retention times of simulated size-exclusion chromatography
SEC) chromatograms for up to four co-eluting proteins [26]. Due
o the interesting ﬁndings of the above study and the efforts neces-
ary for calibrating a statistical model, a further evaluation of MCR
or preparative protein chromatography is of interest.
In this study, we investigated the factorization of UV–vis spec-
ral data from preparative protein chromatography. To increase
pectral differences of proteins, second derivative spectral pre-
reatment was applied. The obtained spectra were analyzed by an
MG-constrained MCR  algorithm. The factorization was  based on
he pure component decomposition (PCD) algorithm originally pro-
osed by Neymeyr et al. [27]. In a ﬁrst case study, three model
roteins (ribonuclease A, cytochrome c, and lysozyme) were sep-
rated by cation-exchange chromatography (CEX). A second case
tudy factorized an augmented data matrix from multiple binary
lutions of the model proteins cytochrome c and lysozyme. A
hird case study monitored the separation of a surrogate ADC from
ts unconjugated IgG by hydrophobic-interaction chromatography
HIC). In all case studies, the estimated concentration proﬁles were
ompared to off-line analytics. The estimated spectra of the three
ase studies were compared to a protein spectral library.
. Theory
.1. MCR  by PCD
Considering a spectroscopic transmission measurement, the
bsorbance generally follows the Lambert–Beer law. For a multi-
avelength and multi-component case, it reads:
 = CST + E, (1)
here A ∈ Rn×m is the absorbance matrix, C ∈ Rn×o is the concen-
ration matrix, S ∈ Rm×o is the spectral matrix, and E ∈ Rn×m is
he residual matrix. n, m,  and o refer to the number of samples, the
umber of wavelengths, and the number of species, respectively.
The goal of MCR  is to retrieve approximate C and S from A under
ertain constraints such as the chromatographic elution proﬁle. As
roposed by Sawall et al. [28], this can be formulated by adapting
he PCD algorithm [27] as a minimization problem of the function
(C, S, p) = ||A − CST ||2F + fhard(C, S, p). (2)
he ﬁrst part on the right-hand side consists of the squared Frobe-
ius matrix norm of the residual matrix E. It thus describes the
eviation of the product of the computed matrices C and S from the
bsorbance data. For a good solution, the Frobenius norm should
e close to zero. The second part fhard(C, S, p) deﬁnes an error term
or additional hard constraints which are discussed in Section 2.2.
 are the parameters for the hard constraints. For the current appli-
ation, fhard(C, S, p) was multiplied by a weighting factor  = 100 to
enalize deviations from the hard constraints strongly [28].
Estimating C and S can be difﬁcult, as both matrices may contain
 large number of entries. It was previously proposed to retrieve
stimates of C and S by rotating a limited number of factors fromA 1585 (2019) 152–160 153
an easy-to-compute matrix factorization scheme such as singular
value decomposition (SVD) [29,27,28] or principal component anal-
ysis (PCA) [30]. SVD factorizes the original absorbance matrix into
the matrices U ∈ Rn×n,  ∈ Rn×m, and V ∈ Rm×m according to
A = UVT . (3)
U and V are orthonormal matrices.  is a rectangular diagonal
matrix with the singular values si on the diagonal. The entries are
ordered according to their magnitude, i.e. s1 ≥ s2 ≥ · · · ≥0. The orig-
inal matrix A can now be low-rank approximated with only a small
number of q singular values ˜ = (1 : q, 1 : q) and singular vectors
U˜ = U(:, 1 : q), V˜ = V(:, 1 : q). The number of included factors needs
to be evaluated depending on the experiment. Often, q is equal to
the number of species in the mixture o. Importantly, the low-rank
approximation by SVD captures the maximum possible amount of
variance from A with the given number of factors q.
The concentration matrix C and spectral matrix S can now be
approximated as a rotation of the singular vectors by T ∈ Ro×q.
A˜ = U˜˜V˜T = U˜˜T−1︸  ︷︷  ︸
=C
TV˜T︸︷︷︸
=ST
(4)
T−1 denotes the matrix inverse. If o /= q, T−1 is replaced by pseudo
inverse T+. Neymeyr et al. proved that a perfect reconstruction of C
and S in Eq. (4) is possible in the absence of noise [27]. The objective
function is now reformulated to
G(T, p) = F(U˜˜T−1, V˜TT , p). (5)
Through the low-rank approximation of A, the matrix factorization
problem is thus simpliﬁed to estimating o × q rotational parameters
and p.
2.2. Formulation of the EMG hard constraint
It is worth noting that Eq. (1) and the Frobenius norm in Eqs. (2)
and (5) do not take into account any time correlation of the concen-
tration. Thus, any intended time correlation needs to be captured
by fhard(C, S, p). In chromatography, the elution of different com-
ponents is often empirically described as EMG curves [1]. An EMG
describes a Gaussian peak convoluted with a continuously stirred
tank reactor. It is selected as a hard constraint on the columns of C. A
similar approach was  recently taken by Arase et al. who  factorized
analytical chromatograms of small molecules by MCR  with a bidi-
rectional EMG  constraint [31]. In this work, the EMG  computation
c(t;h, , , ) proposed by Kalambet et al. is used [32].
c(t; h, , , )=
⎧⎪⎪⎪⎪⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎪⎪⎪⎪⎩
h · 

·
√

2
· exp
(
 − t

+ 
2
22
)
· erfc(z), if z ≤ 0,
h · 

·
√

2
· exp
(
− ( − t)
2
22
)
· erfcx(z), if 0 < z≤6.71 · 107,
h  ·
exp
(
− ( − )
2
22
)
1 + ( − t) · 
2
, else,
(6)
z = 1√
2
(
 − t

+ 

)
. (7)
Here, t refers to the time. h is a scaling factor of the EMG.   and
 denote the mean value and standard deviation of a Gaussian
peak before convolution.  is the decay constant of the continuously
stirred tank reactor. Additionally, fronting can be implemented by
reﬂecting t at  for negative , i.e. tˆ = 2 − t and c(tˆ; , , −) if
 < 0.
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Table 1
All proteins used for this study are listed with their respective manufacturers.
Protein Manufacturer
Ribonuclease A from bovine pancreas Sigma Aldricha
Cytochrome c from bovine heart Sigma Aldrich
Lysozyme from chicken egg Sigma Aldrich
IgG1 MedImmuneb
IgG2 Lek Pharmaceuticalsc
Ovomucoid Sigma Aldrich
Bovine serum albumin Sigma Aldrich
apo-Transferrin human Sigma Aldrich
Myoglobin from equine skeletal muscle Sigma Aldrich
Glucose oxidase from aspergillus niger Sigma Aldrich
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ta St. Louis, USA.
b Gaithersburg, USA.
c Ljubljana, SL.
For each species, an EMG  peak shape is now included as a hard
onstraint in fhard(C, A, p) and evaluated at every measured time
oint tj of the absorbance matrix.
hard(C, A, p) =
n∑
i=1
o∑
j=1
(
Cij − c (ti; p(:, j))
)2
, (8)
here p is the parameter matrix containing 4 × o entries. As the
MG is positive for h > 0, a constraint on C ≥ 0 is implicitly set. Due to
he application to second derivative spectra, the spectral matrix S is
ot ≥0 but may  also have negative entries. As a result, no constraint
n the positivity of the spectral matrix must be set.
The objective function G(T, p) can now be solved with a deter-
inistic numerical solver. We  used a quasi-Newton approach as
mplemented in MATLAB (version 2016a, The Mathworks, Naticks,
SA). For our purposes, the optimization is split into multiple sub-
tages. First, only p is released for optimization. Next, T is optimized
or the estimated p. After convergence, the EMG  scaling factors
 are multiplied into the rotational matrix T. Finally, all remain-
ng parameters are released for optimization until convergence is
chieved. The staged approach helps to prevent the solver from
iverging.
. Materials and methods
.1. Proteins and buffers
In Table 1, the proteins used in this paper, and their respec-
ive manufacturer are listed. All protein solutions and buffers were
roduced with Ultrapure Water (PURELAB Ultra, ELGA LabWater,
eolia Water Technologies, Saint-Maurice, France). After thorough
ixing, the buffers were pH-adjusted with HCl, ﬁltrated with cellu-
ose acetate ﬁlters with a pore size of 0.2 m (Sartorius, Göttingen,
ermany), and degassed by soniﬁcation.
.2. Preparative chromatographic instrumentation
The preparative chromatographic runs were performed using a
ustom-made experimental setup consisting of a conventional liq-
id chromatography system and a diode array detector (DAD). The
iquid chromatography system was an ÄKTA puriﬁer 10 equipped
ith pump P-900, sample pump P-960, UV monitor UV-900 (10 mm
ptical path length), conductivity monitor C-900, pH monitor pH-
00, autosampler A-905, and fraction collector Frac-950. The liquid
hromatography system was controlled with UNICORN 5.31 (all GE
ealthcare, Chalfont, St. Giles, UK). In order to obtain in-line UV–vis
bsorption spectra, an UltiMate DAD3000 was added to the ﬂow
ath downstream of the column. The DAD was equipped with a
emi-preparative ﬂow cell (0.4 mm  optical pathlength) except for
he ADC separation where an analytical ﬂow cell (10 mm opticalA 1585 (2019) 152–160
path length) was used. The DAD was  controlled with Chromeleon
6.80 (all Thermo Fisher Scientiﬁc, Waltham, USA). The data acqui-
sition of the DAD was triggered by custom-made software written
in MATLAB and Visual Basic for Applications (VBA, Microsoft, Red-
mond, USA). A detailed description can be found in [16].
3.3. Analytical chromatographic instrumentation
As reference analytics, analytical chromatography was per-
formed with the collected fractions, using a Dionex UltiMate 3000
liquid chromatography system. The system was  composed of a
HPG-3400RS pump, a WPS-3000TFC analytical autosampler, a TCC-
3000RS column thermostat, and a DAD3000RS detector. The system
was controlled by Chromeleon 6.80 (all Thermo Fisher Scientiﬁc).
3.4. Preparative CEX chromatography
Five CEX runs were performed with a 1 ml  MediaScout
MiniChrom column (Atoll, Weingarten, Germany) with dimensions
5 mm × 50 mm prepacked with SP Sepharose FF (GE Healthcare).
First, the column was equilibrated (20 mM sodium phosphate
[Sigma Aldrich], pH 7.0) and then loaded with 500 mg  of each
protein used in the run (injection volume 100 L). Elution was
performed with a linear gradient from 0% to 100% elution buffer
(20 mM sodium phosphate, 500 mM sodium chloride [Merck,
Darmstadt, Germany], pH 7.0). During all runs, the ﬂow rate was
0.2 mL/min, and 200 L fractions were collected. Spectra were
acquired in the range from 240 nm to 310 nm.  Four runs were
executed with a two-component mixture of cytochrome c and
lysozyme. Gradients were run in 1 CV, 3 CV, 5 CV, and 7 CV. Addi-
tionally, a 3 CV run with a three-component system consisting of
lysozyme, cytochrome c, and ribonuclease A was  carried out.
3.4.1. Analytical chromatography
The fractions from preparative CEX chromatography were ana-
lyzed by analytical CEX chromatography on a Proswift SCX-1S
4.6 mm × 50 mm column (Thermo Fisher Scientiﬁc). A ﬂow rate of
1.5 mL/min was  used during the whole run. For each sample, the
column was  ﬁrst equilibrated for 2.5 min  with load buffer (20 mM
TRIS [Merck, Darmstadt, Germany], pH 8.0). Next, 20 L of sam-
ple was  injected into the system and washed for 0.5 min with load
buffer. A bilinear gradient was  performed during the next 4 min
with 0% to 10% (2 min) and 10% to 100% elution buffer (20 mM TRIS,
700 mM sodium chloride [Merck], pH 8.0). Finally, the column was
stripped for 0.5 min  with 100% elution buffer.
3.5. Preparative HIC of a surrogate ADC
The load for the preparative HIC step was produced by
the conjugation reaction of a surrogate drug (7-diethylamino-
3-(4′-maleimidylphenyl)-4-methylcoumarin) with an IgG1. The
resulting surrogate ADC had similar characteristics regarding struc-
ture and hydrophobicity to normal ADCs, however lacked their
toxicity. The load was prepared by mixing IgG 1 with surrogate
ADC to a ﬁnal concentration of 2 g L−1 for each component.
A 1 mL  Toyoscreen 650M Phenyl column was  purchased from
Tosoh (Tokyo, Japan). For the preparative chromatographic run, the
ﬂow rate was  set to 0.2 mL/min. The column was equilibrated for
5 mL  with 25 mM sodium phosphate and 1 M ammonium sulfate at
pH 7.0. 100 L of the load were injected and washed for 2 mL.  Sub-
sequently, a 15 mL  linear gradient was performed with the elution
buffer (18.75 mM phosphate, pH 7.0, 25% (V/V) 2-propanol) from
20% to 70%. The column was stripped with 8 mL  elution buffer. Dur-
ing the whole chromatographic separation, spectra were acquired
togr. A 1585 (2019) 152–160 155
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Fig. 1. Protein spectra from a spectral library are shown. The protein spectra are
F
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n the range from 250 nm to 450 nm.  The eluent was  collected in
00 L fractions in 96-well plates.
.5.1. Analytical chromatography
Analytics were performed by reversed-phase chromatography
o quantify the ADCs as well as the unmodiﬁed IgG1 according to
he protocol. Reduction or different sample preparation were not
equired. An Acquity UPLC Protein BEH C4 column (Waters Corpo-
ation, Milford, USA; 300 A˚, 1.7 m,  2.1 mm × 50 mm)  was  run at a
ow rate of 0.45 mL/min. The column oven was heated to 80 ◦C.
olvent A consisted of 0.1% triuorocetic acid (TFA) in ultrapure
ater. Solvent B was 0.1% TFA in acetonitrile. After equilibration
nd injection at 26% B, the fraction of B was raised to 30%. Next, a
.8 min  gradient from 30% B to 38% B was used for separation of
he conjugate species. The resulting chromatograms yielded peak
reas of unconjugated, mono-conjugated and di-conjugated mono-
lonal antibodies (mAbs). For the current application, all conjugated
pecies were summed.
.6. UV–vis spectral library
For the spectral library, all proteins in Table 1 except the IgG1
nd IgG2 were dissolved at 2.5 g L−1 in 20 mM sodium phosphate
uffer at pH 7.0. The IgG2 was provided as a virus-inactivated solu-
ion from a Protein A puriﬁcation step. It was diluted in phosphate
uffer to 2.5 g L−1. The IgG1 was not included in the spectral library.
Each entry in the spectral library was generated by injecting the
rotein solutions with the autosampler and a 100 L sample loop
nto the chromatography system at a ﬂow rate of 0.2 mL/min. No
olumn was attached to the system. The samples were pumped
hrough the DAD resulting in chromatograms with EMG  peak
hapes due to the system dispersion. To obtain spectra normalized
y mass, the chromatograms were integrated over time for each
avelength i in MATLAB with a trapezoidal integration scheme,
ultiplied by the ﬂow rate u and normalized by the injected mass
 and optical pathlength l.
ref,i
= u
m · l
∫
Ai (t)dt (9).7. Data analysis
All data analysis was performed in MATLAB on a personal
omputer equipped with a Core i5-4440 CPU at 3.10 GHz (Intel,
ig. 2. Spectral changes during elution are illustrated for case study I. On the left side, t
ormalized concentrations of ribonuclease A (green), cytochrome c (red), and lysozyme (b
pectra, bottom: second derivative spectra).relatively uniform with an absorption maximum around 280 nm.  Differences are
visible on the shoulder of the absorption bands and in the through-to-peak distance
between 250 nm and 280 nm.
Santa Clara, USA). The optimization problem was  implemented as
described in Section 2. Second derivatives were taken of the spec-
troscopic data with a second-order Savitzky-Golay ﬁlter [33] with
a 7-point window width. The resulting absorbance matrix A was
used for MCR.
4. Results and discussion
In this publication, the factorization of multivariate UV–vis data
from preparative protein chromatography by MCR  was  tested.
Instead of using the absorbance matrix directly for MCR, spectra
were ﬁrst derived twice. This was  done for two reasons: First, tak-
ing second derivatives of spectral data helps to remove baseline
offsets and measurement drifts [34]. Second, it is also a popular
technique in protein analytics to enhance the UV/Vis ﬁne struc-
ture. Generally, protein UV–vis spectra are relatively uniform with
comparably little variation (see Fig. 1). Taking the second derivative
enhances spectral differences of proteins [35,36]. Contrary to the
original spectra, derived spectra contain positive as well as nega-
tive bands. Thus, no positivity constraint was set on the spectral
matrix S. The positivity of the concentration was enforced by the
EMGs. This approach was evaluated in three case studies.
he absorbance at 280 nm is shown. The absorbance trace is color-coded with the
lue). The spectra in corresponding colors are shown on the right side (top: original
156 M. Rüdt et al. / J. Chromatogr. A 1585 (2019) 152–160
Fig. 3. SVD of the UV–vis spectral data of the ﬁrst case study. The plots show the ﬁrst four left singular vectors (left), the singular values (middle), and the ﬁrst four right
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singular  vectors (right). The right singular vectors are offset to simplify interpretatio
ed:  second singular vector, yellow: third singular vector, violet: fourth singular vect
f  the proteins.
.1. Analysis of a three-component protein chromatogram
Three model proteins (ribonuclease A, cytochrome c, and
ysozyme) were eluted from a CEX column with a 3 CV linear
radient. In Fig. 2, the resulting absorbance at 280 nm is shown.
he normalized protein concentrations were color-coded into the
bsorbance trace. In the same ﬁgure, the time-evolution of the
riginal and derived spectra is depicted. Compared to the origi-
al spectra, the second derivative spectra allow a distinction of the
ifferent components based on spectral features. Furthermore, the
bserved background drift could be reduced.
The second-derivative absorbance matrix A was subsequently
nalyzed by SVD. In Fig. 3, the singular values  as well as the
rst four left and right singular vectors (U and V) are shown. The
ingular values showed an approximate exponential decay over the
rst ﬁve points and ﬂattened out for latter entries. The left and
ight singular vectors one, two, and three only seemed to contain
ittle noise. However, the fourth left singular vector was offset from
ero over the whole elution, i.e. the fourth singular vectors contain
he baseline offset. The fourth right singular vector showed signs
f noise with high ﬂuctuations between subsequent wavelengths.
ased on these observations, it was decided to use the ﬁrst three
ingular vectors for MCR.
For the deterministic optimization of the objective function, ini-
ial values were set for T as well as p. Fig. 3 shows that the ﬁrst
ingular vector followed the total protein concentration while vec-
ors two and three contained information on the time evolution of
he spectral differences of the proteins. Consequently, the extremes
f the vectors coincided with the concentration maxima of the dif-
erent components. Based on this argumentation, the initial MCR
arameters were set based on the SVD. The initial mean values 0
or the EMGs were selected based on the location of the extremes
f the left singular vectors. For the convergence of the algorithm,
t was of major importance to provide good initial values of the
eak location. The initial rotational matrix T0 was established by
nspecting the contribution of the left different singular vectors at
he different 0. If the left singular vector contributed positively
t 0, it was added and otherwise subtracted. To normalize the
agnitude of the contributions, each entry was multiplied by the
ingular value. For the ﬁrst case study, this resulted in the following
otational matrix:
0 = (
−s1 −s2 s3
−s1 −s2 −s3 ). (10)
−s1 s2 s3
The initial standard deviations 0 and decay constants 0 were
et for all proteins to the values 10 and 1, respectively. 0 was vectors are colored according to their column numbers. Blue: ﬁrst singular vector,
s worth noting that the extremes of the left singular vectors occurred during elution
selected to be in the range of the peak widths observed in U. 0
was selected to initially yield an almost symmetric peak. With this
initial set of parameters, the optimization converged in less than
30 s.
In Fig. 4, the optimized MCR  results are shown. The estimated
maximal concentration location from MCR  coincided well with the
results from off-line analytics. The good overall agreement between
MCR  and off-line analytics was  also reﬂected by the high R2 val-
ues. Based on normalized peak areas, values of 0.94, 0.93, and
0.92 were reached for ribonuclease A, cytochrome c and lysozyme,
respectively. Differences in the peak shape were visible especially
regarding peak tailing. As similar differences occurred for all eluted
proteins, the additional tailing in off-line analytics was explained
by the system dispersion between detector and fractionator.
In summary, for a single three-component run, the combination
of MCR  with an EMG  hard constraint and second derivative spectra
provided a good estimation of the elution proﬁle of the different
protein components without prior calibration.
4.2. Simultaneous application to multiple chromatograms
Next, the PCD algorithm was  tested for factorizing multiple
binary chromatograms simultaneously. To this end, the single chro-
matogram absorbance matrices were concatenated column-wise
resulting in Asuper ∈ Rn¯×m with n¯ =
∑
ini and ni being the number
of measurements per run. For all subsequent analyses, Asuper was
used.
Similar to the evaluation of the ternary protein elution, Asuper
was ﬁrst analyzed by SVD (Fig. 5). As expected for a binary mix-
ture, the ﬁrst two singular values were signiﬁcantly larger than
the following. This was also reﬂected by the shape of the singular
vectors. The third left and right singular vectors already contained
a signiﬁcant contribution of baseline drift and noise. Thus, MCR
was performed based on two singular vectors. The initial rotational
matrix was deﬁned in the same manner as described above. As each
chromatography run was  described by two  EMGs and a total of
four runs were performed, a total of eight sets of EMG  parameters
were necessary. Initial parameter assignment followed the same
reasoning as described for the ternary mixture.
After initialization, the optimization converged in a matter of
minutes to the ﬁnal solution (Fig. 6). The peak-maxima locations
were again accurately determined by MCR. Similar to the separa-
tion of the ternary mixture, some deviations could be observed in
the peak height and tailing. This was again attributed to system
dispersion. Interestingly, the differences between off-line analyt-
ics and MCR  estimation were more pronounced for steeper elution
gradients (see Fig. 6A and D). This supported the assumption that
the differences were caused by system dispersion. The steeper gra-
dients resulted in quicker changes in protein concentrations which
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Fig. 4. Chromatogram of the ﬁrst case study as retrieved by MCR and compared to off-line analytics. The dashed red lines show the normalized concentration estimate from
the  hard model. The solid black lines correspond to the rotated left singular vectors. The bars show the measured concentration by off-line analytics. Green: ribonuclease A,
red:  cytochrome c, blue: lysozyme.
Fig. 5. SVD of the UV–vis spectral data of the second case study. The plots show the ﬁrst three left singular vectors (left), the singular values (middle), and the ﬁrst three
right  singular vectors (right). The right singular vectors are offset to simplify interpretation. The vectors are colored according to their column numbers. Blue: ﬁrst singular
vector,  red: second singular vector, yellow: third singular vector.
Fig. 6. Chromatograms of the second case study as retrieved by MCR  and compared to off-line analytics. The four plots show the different runs with varied gradient lengths.
A:  1 CV, B: 3 CV, C: 5 CV, D: 7 CV. The dashed red lines show the normalized concentration estimates from the hard model. The solid black lines correspond to the rotated left
singular  vectors. The bars show the measured concentration by off-line analytics. Red: cytochrome c, blue: lysozyme.
158 M. Rüdt et al. / J. Chromatogr. A 1585 (2019) 152–160
Fig. 7. SVD of the UV–vis spectral data of the third case study. The plots show the ﬁrst three left singular vectors (left), the singular values (middle), and the ﬁrst three right
singular  vectors (right). The right singular vectors are offset to simplify interpretation. The vectors are colored according to their column numbers. Blue: ﬁrst singular vector,
red:  second singular vector, yellow: third singular vector.
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n turn were more affected by mixing and diffusive peak broaden-
ng. Despite these deviations, good estimations were obtained for
he elution of cytochrome c and lysozyme with R2 values of 0.93 and
.91, respectively. Between the concentrations by the rotated sin-
ular vectors and the hard model, only minor differences occurred.
hus, the method could be extended to the case of multiple chro-
atographic runs while still obtaining a stable convergence of the
lgorithm.
.3. Application of MCR  to an ADC puriﬁcation step
In the third case study, an ADC conjugation reaction mixture was
oaded onto a HIC column. This puriﬁcation step aimed to deplete
hemical reactants and separate conjugated from native IgG1. Due
o the reaction chemicals, the loaded mixture was relatively com-
lex. Additionally, the protein concentration during elution was
ower compared to the previous case studies. This increased the
erceived noise level and baseline drift. To simplify the analysis
f the chromatogram, the evaluation focused on the main elution
eak of native, mono-conjugated, and di-conjugated IgG1.
In Fig. 7, the results of an SVD are shown. The ﬁrst two singular
alues were noticeably larger than the following ones. Interest-
ngly, the second left singular vector already contained some
aseline drift. The baseline drift became stronger for the third left
ingular vector. The second right singular vector was not inﬂuenced
y noise and contained strong spectral bands around 384 nm.  These
ands are typical of the used surrogate drug. The third right sin-
ular vector was noticeably deteriorated by noise. Based on these
bservations, two components were included into the MCR  opti-
ization. Optimization of the third case study converged in less-line analytics. The dashed red lines show the normalized concentration estimate
s. The bars show the measured concentration by off-line analytics. Yellow: native
than a minute. The resulting chromatogram is shown in Fig. 8. Sim-
ilar to the previous case studies, the location of the concentration
maxima corresponded well to the off-line analytics. Slight differ-
ences could be observed in tailing and fronting. The good results
were conﬁrmed by the R2 values of 0.99 and 0.97 for the native IgG
and the ADC, respectively. The R2 was again calculated based on the
normalized areas. The better agreement between off-line analytics
and MCR  results were attributed to the long elution gradient which
reduced the effects of system dispersion between detector and frac-
tionator as well as possibly the bigger spectral differences between
the IgG and the ADC. Interestingly, the differences between the
rotated singular vectors and the hard model were bigger in this
case. This was explained by the observed baseline drift included
in the second singular vectors which again is related to the matrix
factorization. SVD captured on each additional dimension as much
variation as possible. The information is however not necessarily
useful for the estimation of the elution proﬁle. Thus, other matrix
factorization approaches may  outperform SVD. Nevertheless, the
used PCD algorithm also in the last case study provided promising
results.
4.4. Protein identiﬁcation based on the estimated spectra
To assess how accurate the MCR  algorithm estimated data in
spectral dimension, the previously estimated spectra were com-
pared to the second derivatives of the spectral library shown
in Fig. 1. Prior to the comparison, all spectra were normal-
ized by standard normal variate transformation to remove any
concentration-related information. In Fig. 9, all spectra were pro-
jected onto a plane by PCA. Estimated spectra were projected into
M. Rüdt et al. / J. Chromatogr. 
Fig. 9. Score plot based on a PCA of the spectral library. The spectra from the protein
library are marked by black circles. The retrieved spectra from MCR  are projected
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he vicinity of the corresponding reference spectra. The results
ere even more pronounced when directly comparing Euclidean
istances between the second derivative spectra. For case study
, the distances between the reference and estimated spectra of
ibonuclease A, cytochrome c, lysozyme were 0.5, 0.6, and 0.3,
espectively. All other distances were ≥1.8. For the second case
tudy, the Euclidean distances were 0.8 for cytochrome c and 0.3
or lysozyme with all other distances being ≥2. For the third case
tudy, only the estimated spectrum from 240 nm tot 310 nm of the
nconjugated IgG1 was used. The ADC could not be evaluated in
his manner, as the drug contributed to the absorption in the pro-
ein spectral range and thus biased an identiﬁcation. The Euclidean
istance from the IgG1 was smallest to the IgG2 with 2.1. All other
istances were ≥2.5. The bigger difference was explained by the
tructural differences of IgG1 to IgG2 next to the error introduced
y the factorization by MCR. The results show, that the estimated
econd derivative spectra of the MCR  algorithm are close to the
pectra of the pure components and may  even be used to draw
onclusions on the generating protein.
. Conclusion
Here, the application of MCR  with hard model constraints on
reparative protein chromatographic data was tested. The results
how that MCR  was well capable of factorizing chromatograms
ven though protein spectra are subject only to small spectral varia-
ion. Differences in peak shape and location of the estimated elution
roﬁles remained small. The matrix factorization of the protein
hromatograms could be directly used for protein identiﬁcation.
n summary, MCR  seems to be a suitable tool for evaluating protein
hromatograms if the eluting species are spectroscopically differ-
nt. For UV–vis spectroscopy, mainly the amount of aromatic amino
cids, the local environment of aromatic amino acids, and disul-
de bridging affect the protein spectra in the investigated spectral
ange [36]. The proposed method may  be especially useful for appli-
ations in process development as it is readily applicable without
rior calibration.
While the current algorithm is limited to EMGs, other curve
hapes could be implemented in a similar manner to also address
ifferent elution behavior. Furthermore, MCR  is not limited to
V–vis spectroscopy. Other PAT sensors may  beneﬁt from its appli-
ation as long as they follow a bilinear relation. These occur for
any (process) analytical technologies including IR spectroscopy,
aman spectroscopy, and on-/at-/off-line HPLC. In consequence, a
[A 1585 (2019) 152–160 159
wide variety of applications in biopharmaceutical puriﬁcation are
conceivable and may  be explored in future.
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